MedTrace Logo

COPD on Primary Care Treatment (COOPT)

NCT00184977 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 270

Last updated 2010-03-12

No results posted yet for this study

Summary

The aim of this family practice based study is to determine the long-term treatment effects of two drugs that are presumed to modify the course and progression of chronic obstructive pulmonary disease (COPD), oral N-acetylcysteine and inhaled corticosteroids.

Conditions

  • Pulmonary Disease, Chronic Obstructive
  • Lung Diseases, Obstructive
  • Bronchitis, Chronic

Interventions

DRUG

N-acetylcysteine

DRUG

fluticasone propionate

Sponsors & Collaborators

  • Dutch Health Care Insurance Board (CVZ)

    collaborator UNKNOWN

  • GlaxoSmithKline

    collaborator INDUSTRY

  • Zambon SpA

    collaborator INDUSTRY

  • The Netherlands Asthma Foundation

    collaborator OTHER

  • Radboud University Medical Center

    lead OTHER

Principal Investigators

  • Tjard RJ Schermer, MSc, PhD · Radboud University Nijmegen Medical Centre, Department of Family Medicine

  • Chris van Weel, MD, PhD · Radboud University Nijmegen Medical Centre, Department of Family Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1998-12-31
Completion
2003-01-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00184977 on ClinicalTrials.gov